This suggests that discrete host-microbiota interactions are associated with specific CRS phenotypes and opens the possibility of more targeted therapy e.g., anti-IL5 or specific probiotic taxa for subsets of CRS patients who exhibit Corynebacterium-dominated sinus mucosal microbiota and increased IL5. Here, IL5 is linked to congenital rubella syndrome.